DCGI gives emergency-use approval to Covaxin, Covishield vaccines
India's drugs regulator DCGI says it has approved Oxford-Serum Institute's COVID-19 vaccine Covishield and Bharat Biotech's Covaxin for restricted emergency-use. Listen-in.
READ MORE:
Other Healthcare/Biotech Videos
AI in Pharma: How India's Drug Giants Are Betting Big on Artificial Intelligence
AI in Pharma: How India's Drug Giants Are Betting Big on Artificial Intelligence
The brutal leadership lesson that shaped Dr. Reddy’s chief
We are discovery rich, but development poor
Budget 2026: India’s pharma leap, BioPharma SHAKTI gets ₹10K cr; 1,000 clinical trial sites planned
